Cargando…
Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3
The interplay between viral and host proteins has been well studied to elucidate virus-host interactions and their relevance to virulence. Mammalian genes encode apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins, which act as intrinsic restriction factors against l...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432859/ https://www.ncbi.nlm.nih.gov/pubmed/28331087 http://dx.doi.org/10.1128/JVI.00250-17 |
_version_ | 1783236727791419392 |
---|---|
author | Yoshikawa, Rokusuke Takeuchi, Junko S. Yamada, Eri Nakano, Yusuke Misawa, Naoko Kimura, Yuichi Ren, Fengrong Miyazawa, Takayuki Koyanagi, Yoshio Sato, Kei |
author_facet | Yoshikawa, Rokusuke Takeuchi, Junko S. Yamada, Eri Nakano, Yusuke Misawa, Naoko Kimura, Yuichi Ren, Fengrong Miyazawa, Takayuki Koyanagi, Yoshio Sato, Kei |
author_sort | Yoshikawa, Rokusuke |
collection | PubMed |
description | The interplay between viral and host proteins has been well studied to elucidate virus-host interactions and their relevance to virulence. Mammalian genes encode apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins, which act as intrinsic restriction factors against lentiviruses. To overcome APOBEC3-mediated antiviral actions, lentiviruses have evolutionarily acquired an accessory protein, viral infectivity factor (Vif), and Vif degrades host APOBEC3 proteins via a ubiquitin/proteasome-dependent pathway. Although the Vif-APOBEC3 interaction and its evolutionary significance, particularly those of primate lentiviruses (including HIV) and primates (including humans), have been well investigated, those of nonprimate lentiviruses and nonprimates are poorly understood. Moreover, the factors that determine lentiviral pathogenicity remain unclear. Here, we focus on feline immunodeficiency virus (FIV), a pathogenic lentivirus in domestic cats, and the interaction between FIV Vif and feline APOBEC3 in terms of viral virulence and evolution. We reveal the significantly reduced diversity of FIV subtype B compared to that of other subtypes, which may associate with the low pathogenicity of this subtype. We also demonstrate that FIV subtype B Vif is less active with regard to feline APOBEC3 degradation. More intriguingly, we further reveal that FIV protease cleaves feline APOBEC3 in released virions. Taken together, our findings provide evidence that a lentivirus encodes two types of anti-APOBEC3 factors, Vif and viral protease. IMPORTANCE During the history of mammalian evolution, mammals coevolved with retroviruses, including lentiviruses. All pathogenic lentiviruses, excluding equine infectious anemia virus, have acquired the vif gene via evolution to combat APOBEC3 proteins, which are intrinsic restriction factors against exogenous lentiviruses. Here we demonstrate that FIV, a pathogenic lentivirus in domestic cats, antagonizes feline APOBEC3 proteins by both Vif and a viral protease. Furthermore, the Vif proteins of an FIV subtype (subtype B) have attenuated their anti-APOBEC3 activity through evolution. Our findings can be a clue to elucidate the complicated evolutionary processes by which lentiviruses adapt to mammals. |
format | Online Article Text |
id | pubmed-5432859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-54328592017-06-01 Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 Yoshikawa, Rokusuke Takeuchi, Junko S. Yamada, Eri Nakano, Yusuke Misawa, Naoko Kimura, Yuichi Ren, Fengrong Miyazawa, Takayuki Koyanagi, Yoshio Sato, Kei J Virol Virus-Cell Interactions The interplay between viral and host proteins has been well studied to elucidate virus-host interactions and their relevance to virulence. Mammalian genes encode apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3) proteins, which act as intrinsic restriction factors against lentiviruses. To overcome APOBEC3-mediated antiviral actions, lentiviruses have evolutionarily acquired an accessory protein, viral infectivity factor (Vif), and Vif degrades host APOBEC3 proteins via a ubiquitin/proteasome-dependent pathway. Although the Vif-APOBEC3 interaction and its evolutionary significance, particularly those of primate lentiviruses (including HIV) and primates (including humans), have been well investigated, those of nonprimate lentiviruses and nonprimates are poorly understood. Moreover, the factors that determine lentiviral pathogenicity remain unclear. Here, we focus on feline immunodeficiency virus (FIV), a pathogenic lentivirus in domestic cats, and the interaction between FIV Vif and feline APOBEC3 in terms of viral virulence and evolution. We reveal the significantly reduced diversity of FIV subtype B compared to that of other subtypes, which may associate with the low pathogenicity of this subtype. We also demonstrate that FIV subtype B Vif is less active with regard to feline APOBEC3 degradation. More intriguingly, we further reveal that FIV protease cleaves feline APOBEC3 in released virions. Taken together, our findings provide evidence that a lentivirus encodes two types of anti-APOBEC3 factors, Vif and viral protease. IMPORTANCE During the history of mammalian evolution, mammals coevolved with retroviruses, including lentiviruses. All pathogenic lentiviruses, excluding equine infectious anemia virus, have acquired the vif gene via evolution to combat APOBEC3 proteins, which are intrinsic restriction factors against exogenous lentiviruses. Here we demonstrate that FIV, a pathogenic lentivirus in domestic cats, antagonizes feline APOBEC3 proteins by both Vif and a viral protease. Furthermore, the Vif proteins of an FIV subtype (subtype B) have attenuated their anti-APOBEC3 activity through evolution. Our findings can be a clue to elucidate the complicated evolutionary processes by which lentiviruses adapt to mammals. American Society for Microbiology 2017-05-12 /pmc/articles/PMC5432859/ /pubmed/28331087 http://dx.doi.org/10.1128/JVI.00250-17 Text en Copyright © 2017 Yoshikawa et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Virus-Cell Interactions Yoshikawa, Rokusuke Takeuchi, Junko S. Yamada, Eri Nakano, Yusuke Misawa, Naoko Kimura, Yuichi Ren, Fengrong Miyazawa, Takayuki Koyanagi, Yoshio Sato, Kei Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 |
title | Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 |
title_full | Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 |
title_fullStr | Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 |
title_full_unstemmed | Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 |
title_short | Feline Immunodeficiency Virus Evolutionarily Acquires Two Proteins, Vif and Protease, Capable of Antagonizing Feline APOBEC3 |
title_sort | feline immunodeficiency virus evolutionarily acquires two proteins, vif and protease, capable of antagonizing feline apobec3 |
topic | Virus-Cell Interactions |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432859/ https://www.ncbi.nlm.nih.gov/pubmed/28331087 http://dx.doi.org/10.1128/JVI.00250-17 |
work_keys_str_mv | AT yoshikawarokusuke felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT takeuchijunkos felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT yamadaeri felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT nakanoyusuke felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT misawanaoko felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT kimurayuichi felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT renfengrong felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT miyazawatakayuki felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT koyanagiyoshio felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 AT satokei felineimmunodeficiencyvirusevolutionarilyacquirestwoproteinsvifandproteasecapableofantagonizingfelineapobec3 |